Bio-Techne Corporation

Laboratory and Research Supplies and Equipment

New miRNAscope Assay Detects Ultra-Short Molecules in Native Tissue

Utilizes signal amplification and background suppression technology to deliver researchers with elevated specificity, sensitivity and high signal-to-noise detection. Enables in-situ detection of short nucleic acid targets between 17-50 nucleotides which includes microRNAs, RNAs (siRNAs) and antisense oligonucleotides (ASOs). Offers RNAscope technology for spatial visualization of single-molecule...

Read More »
Health, Medical, & Dental Supplies and Equipment

Bio-Techne's New Exosome-based Liquid Biopsies Helping to Advance Personalized Care in Lung Cancer Diagnostics

Minneapolis, May 28, 2019 /PRNewswire/ -- Bio-Techne today announced the publication of a recent validation study demonstrating that the proprietary exosome-based liquid biopsy tests from Bio-Techne's Exosome Diagnostics brand may be used to assess the mutational status of the Epidermal Growth Factor Receptor (EGFR) gene in patients with non-small cell lung cancer (NSCLC). The data from...

Read More »
Company News

Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb

Minneapolis, March 26, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its R&D Systems and Novus brands have been named winners of the CiteAb COVID-19 Innovation Award.  This award celebrates innovative solutions or products that helped shape the life sciences sectors understanding of, or resilience to COVID-19.  The COVID-19 Innovation Award reflects...

Read More »
Company News

Bio-Techne Announces ISO 14001:2015 Certification for The EMEA Region of Bio-Techne

Minneapolis, Feb. 25, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of proteins, antibodies and cytokines today announced that its sites in Abingdon, Langley, Rennes and Wiesbaden received ISO 14001:2015 certification for Environmental Management Systems. These Bio-Techne facilities provide Sales, Marketing, Purchasing, Order Processing, Warehousing,...

Read More »
Company News

Bio-Techne and Luminary Therapeutics Sign License Agreement for Use of Bio-Techne's TcBuster™ for the Development of Luminary's CAR-T Cell Therapies

MINNEAPOLIS, Feb. 23, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of a license agreement with Luminary Therapeutics for the use of TcBuster™ for the manufacturing of gene-modified cell therapies. TcBuster is Bio-Techne's proprietary non-viral transposon-based gene delivery system used to advance cell therapy manufacturing.  Under the terms of...

Read More »
Company News

Bio-Techne Announces Opening of New Canadian Facility

Minneapolis, Oct. 1, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the opening of its new Canadian office located in Toronto. This new office will be the workplace for approximately 40 Bio-Techne employees and reflects the Company's commitment to supporting the Canadian life sciences industry as well as expectations for continued growth in this geography....

Read More »
Laboratory and Research Supplies and Equipment

New miRNAscope Assay Detects Ultra-Short Molecules in Native Tissue

Utilizes signal amplification and background suppression technology to deliver researchers with elevated specificity, sensitivity and high signal-to-noise detection. Enables in-situ detection of short nucleic acid targets between 17-50 nucleotides which includes microRNAs, RNAs (siRNAs) and antisense oligonucleotides (ASOs). Offers RNAscope technology for spatial visualization of single-molecule...

Read More »
Company News

Bio-Techne Attains ISO 9001:2015 Certification for Fetal Bovine Serum Manufacturing Facility

MINNEAPOLIS, Sept. 16, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media manufacturing facility in Flowery Branch, Georgia. ISO 9001:2015 is an international Business Quality Management System standard that is recognized globally as an indicator of quality excellence....

Read More »
Company News

Bio-Techne China Recognized with Decade of Contribution Award

MINNEAPOLIS, June 26, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) was recently honored with the "Decade of Contribution Award" at the 2019 (10th) International Conference on Cell Therapy conference. This award recognized the commitment of Bio-Techne's team in China to providing comprehensive support and reliable products and services for the Chinese Biotechnology...

Read More »

All Topics